Sharlene Gill, BSc (Pharm), MD, MPH, MBA, FACP, FRCP(C)
Dr. Sharlene Gill is a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver. She received a BSc. in Pharmacy, and MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology, subsequently completing a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Masters of Public Health from the Harvard School of Public Health (Boston, MA) before returning to Vancouver where she is presently Professor of Medicine at the University of British Columbia. In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina. Her areas of clinical expertise are in colorectal, pancreatic and hepatobiliary cancers. She is actively engaged in education and research, with over 95 peer-reviewed publications and book chapters to her credit. Her academic focus is in the areas of health outcomes and clinical trials research – she currently serves as the Chair for the GI Disease site of the Canadian Cancer Trials Group (CCTG).